EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – Phase 3 protocol submitted with FDA ...
EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis - Phase 3 protocol submitted with FDA feedback expected imminently; incremental data submitted ...
Positive topline Phase 1 data for BGE-102, demonstrating potential best-in-class reductions among oral NLRP3 inhibitors in inflammatory ...
As Health Secretary Robert F. Kennedy Jr. prepares to wean the country off mental health medications, U.S. Health Department ...
The scientists supposedly all had access to sensitive government research, and the nature of their work has led to ...
With cutting-edge sports medicine and sci-fi gadgetry, more and more athletes are figuring out how to extend their careers.
Before Lerone Martin joined Stanford in 2022 as director of the Martin Luther King Jr. Research and Education Institute, he ...
One day, I got a call from Peter Bahouth, a former Greenpeace honcho whom Ted Turner had swiped to run his grant-making ...
The Court examined whether criminal proceedings could be quashed despite serious allegations involving disrespect to a national icon. It held that genuine remorse and educational reform satisfied the ...
Sunoco LP (NYSE: SUN) ("SUN" or the "Partnership") and SunocoCorp LLC (NYSE: SUNC) ("SUNC") today reported financial and operating results for the quarter ended March 31, 2026.
Times reporters and editors are digging through millions of pages of Jeffrey Epstein documents released by the Justice Department, and tracking the fallout. Times reporters and editors are digging ...
Discover how Anthropic's Claude integrates directly into Microsoft PowerPoint to automate presentation design using Opus 4.6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results